SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H. G. Bone, D. W. Dempster, J. A. Eisman, S. L. Greenspan, M. R. McClung, T. Nakamura, S. Papapoulos, W. J. Shih, A. Rybak-Feiglin, A. C. Santora, N. Verbruggen, A. T. Leung, A. Lombardi, Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial, Osteoporosis International, 2014,

    CrossRef

  2. 2
    Hui-Fang Liu, Lin Yang, Hong-Chen He, Jun Zhou, Ying Liu, Chun-Yan Wang, Yuan-Chao Wu, Cheng-Qi He, Pulsed electromagnetic fields on postmenopausal osteoporosis in southwest China: A randomized, active-controlled clinical trial, Bioelectromagnetics, 2013, 34, 4
  3. 3
    Dima L. Diab, Nelson B. Watts, Paul D. Miller, Osteoporosis, 2013,

    CrossRef

  4. 4
    Robert R. Recker, Laura Armas, The Effect of Antiresorptives on Bone Quality, Clinical Orthopaedics and Related Research®, 2011, 469, 8, 2207

    CrossRef

  5. 5
    Susan L. Greenspan, Subashan Perera, Robert Recker, Julie M. Wagner, Parmatma Greeley, Bryon R. Gomberg, Pamela Seaman, Michael Kleerekoper, Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy, Bone, 2010, 46, 4, 1006

    CrossRef

  6. 6
    Kyu-Tae Hwang, Byeong-Wook Yoo, Yee-Suk Kim, Il-Yong Choi, Young-Ho Kim, Persistency and Change of the Bone Mineral Density with Alendronate Treatment after Hip Fracture, The Journal of the Korean Hip Society, 2010, 22, 4, 312

    CrossRef

  7. 7
    J. F. Aloia, S. Arunabh-Talwar, S. Pollack, J. K. Yeh, The remodeling transient and the calcium economy, Osteoporosis International, 2008, 19, 7, 1001

    CrossRef

  8. 8
    Ching-Jen Wang, Feng-Sheng Wang, Kuender D. Yang, Chung-Cheng Huang, Mel Shiuann-Sheng Lee, Yi-Sheng Chan, Jun-Wen Wang, Jih-Yang Ko, Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate, Archives of Orthopaedic and Trauma Surgery, 2008, 128, 9, 901

    CrossRef

  9. 9
    E. Seeman, Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?, Bone, 2007, 41, 3, 308

    CrossRef

  10. 10
    Michelle L. Frost, Gary J.R. Cook, Glen M. Blake, Paul K. Marsden, Ignac Fogelman, The Relationship Between Regional Bone Turnover Measured Using 18F-fluoride Positron Emission Tomography and Changes in BMD Is Equivalent to That Seen for Biochemical Markers of Bone Turnover, Journal of Clinical Densitometry, 2007, 10, 1, 46

    CrossRef

  11. 11
    Robert P Heaney, Alendronate plus cholecalciferol for the treatment of osteoporosis, Women's Health, 2006, 2, 1, 23

    CrossRef

  12. 12
    P J J Prinsloo, D J Hosking, Alendronate sodium in the management of osteoporosis, Therapeutics and Clinical Risk Management, 2006, 2, 3, 235

    CrossRef

  13. 13
    S. BOONEN, D. VANDERSCHUEREN, P. HAENTJENS, P. LIPS, Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update, Journal of Internal Medicine, 2006, 259, 6
  14. 14
    J. Mark Wilkinson, Alison C. Eagleton, Ian Stockley, Nicola F. A. Peel, Andrew J. Hamer, Richard Eastell, Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: A randomized trial, Journal of Orthopaedic Research, 2005, 23, 1
  15. 15
    Paul D. Miller, Marc C. Hochberg, Lois E. Wehren, Philip D. Ross, Richard D. Wasnich, How useful are measures of BMD and bone turnover?*, Current Medical Research and Opinion, 2005, 21, 4, 545

    CrossRef

  16. 16
    Robert P. Heaney, Connie M. Weaver, Newer Perspectives on Calcium Nutrition and Bone Quality, Journal of the American College of Nutrition, 2005, 24, sup6, 574S

    CrossRef

  17. 17
    Raewyn Poulsen, Marlena Kruger, Food-Drug Synergy and Safety, 2005,

    CrossRef

  18. 18
    Jeffry S. Nyman, Oscar C. Yeh, Scott J. Hazelwood, R.Bruce Martin, A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage, Bone, 2004, 35, 1, 296

    CrossRef

  19. 19
    Dominique P. Pioletti, Lalao R. Rakotomanana, Can the increase of bone mineral density following bisphosphonates treatments be explained by biomechanical considerations?, Clinical Biomechanics, 2004, 19, 2, 170

    CrossRef

  20. 20
    Robert P. Heaney, Phosphorus Nutrition and the Treatment of Osteoporosis, Mayo Clinic Proceedings, 2004, 79, 1, 91

    CrossRef

  21. 21
    Lois E. Wehren, David Hosking, Marc C. Hochberg, Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis, Current Medical Research and Opinion, 2004, 20, 4, 525

    CrossRef

  22. 22
    Babul Borah, Thomas E Dufresne, Paula A Chmielewski, Troy D Johnson, Arkadi Chines, Michael D Manhart, Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography, Bone, 2004, 34, 4, 736

    CrossRef

  23. 23
    Henry G. Bone, David Hosking, Jean-Pierre Devogelaer, Joseph R. Tucci, Ronald D. Emkey, Richard P. Tonino, Jose Adolfo Rodriguez-Portales, Robert W. Downs, Jayanti Gupta, Arthur C. Santora, Uri A. Liberman, Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women, New England Journal of Medicine, 2004, 350, 12, 1189

    CrossRef

  24. 24
    Yu Z Bagger, László B Tankó, Peter Alexandersen, Pernille Ravn, Claus Christiansen, Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal, Bone, 2003, 33, 3, 301

    CrossRef

  25. 25
    Robert P Heaney, Connie M Weaver, Calcium and vitamin D, Endocrinology and Metabolism Clinics of North America, 2003, 32, 1, 181

    CrossRef

  26. 26
    Robert P Heaney, Is the paradigm shifting?, Bone, 2003, 33, 4, 457

    CrossRef

  27. 27
    Amos Pines, Nachman Eckstein, Gideon Kopernik, Daniel Ayalon, Doron Comaneshter, Yair Frenkel, Month 3 and month 6 measurements of bone mineral density predict the annual outcome in postmenopausal women with osteoporosis in whom alendronate was added to long-term HRT, Maturitas, 2003, 44, 4, 287

    CrossRef

  28. 28
    P Ravn, G Neugebauer, C Christiansen, Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis, Bone, 2002, 30, 1, 320

    CrossRef

  29. 29
    E.F Eriksen, F Melsen, E Sod, I Barton, A Chines, Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis, Bone, 2002, 31, 5, 620

    CrossRef

  30. 30
    Brian Gulson, Karen Mizon, Howard Smith, John Eisman, Jacqueline Palmer, Michael Korsch, John Donnelly, Kay Waite, Skeletal Lead Release during Bone Resorption: Effect of Bisphosphonate Treatment in a Pilot Study, Environmental Health Perspectives, 2002, 110, 10, 1017

    CrossRef

  31. 31
    C.J Hernandez, G.S Beaupré, R Marcus, D.R Carter, A theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment, Bone, 2001, 29, 6, 511

    CrossRef

  32. 32
    Sue A. Shapses, Nancy L. Von Thun, Steven B. Heymsfield, Trina A. Ricci, Margaret Ospina, Richard N. Pierson, Theodore Stahl, Bone Turnover and Density in Obese Premenopausal Women During Moderate Weight Loss and Calcium Supplementation, Journal of Bone and Mineral Research, 2001, 16, 7
  33. 33
    Robert P. Heaney, Methods in Nutrition Science, Nutrition Reviews, 2001, 59, 10
  34. 34
    P Ravn, B Clemmesen, C Christiansen, Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women, Bone, 1999, 24, 3, 237

    CrossRef

  35. 35
    Craig D. Rubin, Southwestern Internal Medicine Conference, The American Journal of the Medical Sciences, 1999, 318, 3, 158

    CrossRef

  36. 36
    J.L. Ferretti, Hans Schiessl, H.M. Frost, On New Opportunities for Absorptiometry, Journal of Clinical Densitometry, 1998, 1, 1, 41

    CrossRef

  37. 37
    Nelson B. Watts, TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES, Endocrinology and Metabolism Clinics of North America, 1998, 27, 2, 419

    CrossRef

  38. 38
    Robert P. Heaney, Whole organism physiology and ethnic differences in bone, Journal of Laboratory and Clinical Medicine, 1998, 132, 5, 358

    CrossRef

  39. 39
    David W. Dempster, Exploiting and Bypassing the Bone Remodeling Cycle to Optimize the Treatment of Osteoporosis, Journal of Bone and Mineral Research, 1997, 12, 8